MPM. P. Prokhorova

M. P. Prokhorova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


M. P. Prokhorova has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ARTIFICIAL INTELLIGENCE IN PEDIATRICS: CURRENT STATUS AND PROSPECTS

    by O. Volosovets, S. Kryvopustov, M. Prokhorova, I. Burlaka, A. Volosovets, I. Loginova, M. Kryvopustova, N. Slyusar

    Artificial intelligence (AI) has brought about a technological revolution in post-industrial society, education, and science, and now holds significant potential to improve medical care for children. Objective: To summarize the latest achievements in research and clinical application of AI in pediatrics and to identify promising areas for its application, based on a review of the published literature. Materials and methods. Scientific sources were identified and analyzed through a systematic search of the PubMed database (https://pubmed.ncbi.nlm.nih.gov/), restricted to publications from the preceding 10 years. Pediatrics currently ranks among the top five medical fields by the number of research projects and innovations involving AI tools implemented in 2025. Leading specialties, from oncology to pediatrics, are substantially ahead of other clinical fields, reflecting a concentration of investment and research effort in these areas. During the preceding decade, the number of scientific publications on AI applications in pediatrics increased 22.5-fold — from 145 in 2016 to 3,271 in 2025. he highest publication volumes were recorded in pediatric surgery (596), pediatric hematology (485), pediatric radiology (373), and oncology (273), confirming that AI tools are being adopted most rapidly in subspecialties where large volumes of digital diagnostic data are generated — including plain radiographs, computed tomography, magnetic resonance imaging, and intraoperative video streams. Nevertheless, AI implementation continues to face technical challenges associated with data quality and bias, as well as ethical, privacy, regulatory, economic, and accessibility concerns. Priority areas for AI application encompass diagnostic and prognostic analytics based on neural networks, remote patient monitoring via digital health applications, epidemiological research utilizing large-scale datasets, robotic-assisted surgery and rehabilitation, and three-dimensional (3D) printing for the fabrication of personalized medical devices and drug delivery systems.

  • Open Access

    Comparative analysis of sublingual and subcutaneous allergen-specific immunotherapy in children with bronchial asthma sensitized to pollen allergens: effect on cytokine profile and immune response

    by M.P. Prokhorova, A.V. Kupkina

    Background. Allergen-specific immunotherapy is currently the only disease-modifying treatment for allergic disea­ses. Among its delivery methods, sublingual (SLIT) and subcutaneous (SCIT) immunotherapy are commonly used. However, comparative data on their efficacy and influence on immune response in pediatric patients remain limited. The purpose was to compare the effectiveness of SLIT and SCIT in children with ato­pic bronchial asthma, focusing on their impact on cytokine profile and immune response. Materials and methods. A total of 70 children aged 5–17 years with mild to moderate bronchial asthma and sensibilization to pollen allergens were enrolled and randomized into two groups: group 1 (n = 35) — SLIT and group 2 (n = 35) — SCIT. A control group of 30 healthy children was included for baseline comparison. The follow-up duration was 1 year. Dyna­mics of clinical symptoms, eosinophilic inflammation, cellular and humoral immunity indicators, and IL-1β and IL-4 cytokines were assessed. Results. In both groups, a significant improvement in disease control was observed: a decrease in the total score of clinical manifestations of asthma (by 83.4 and 81.3 % in groups 1 and 2, respectively), symptom frequency (by 92.5 and 89.5 %), and the need to use rescue medication (by 95.3 and 93.4 %). A comparable reduction in eosinophilic inflammation was noted: the level of eosinophils in nasal secretion decreased from 34.6 ± 0.6 % to 15.4 ± 0.8 % in group 1 and from 38.9 ± 1.8 % to 16.3 ± 0.5 % in group 2; in peripheral blood — from 14.5 ± 0.5 % to 6.2 ± 1.5 % and from 15.8 ± 0.7 % to 6.3 ± 0.5 %, respectively. Both me­thods of allergen-specific immunotherapy led to a decrease in IgE, an increase in IgA (p < 0.001), and positive shifts in cellular immunity. The immunoregulatory index increased in the SLIT group from 1.07 ± 0.21 to 1.25 ± 0.17 (p < 0.05), in the SCIT group from 1.15 ± 0.11 to 1.18 ± 0.24 (p > 0.05). A comparable modification of the cytokine profile was found: a decrease in IL-1β (p < 0.05) and IL-4 (p < 0.001) without a statistically significant difference between the groups (p = 0.071 and p = 0.112). Conclusions. SLIT and SCIT have comparable effectiveness in the treatment of children with atopic bronchial asthma, demonstrating comparable effects on immunity and cytokine profile. Both methods provide the formation of immunological tolerance to allergens, suppression of Th2 inflammation and a shift of the immune response towards the Th1 type, which indicates their ability not only to alleviate symptoms, but also to modify the course of the disease.

  • Open Access

    Deterioration of health of infants during the war and COVID-19 pandemic in Ukraine

    by O.P. Volosovets, S.P. Kryvopustov, A.YA. Kuzmenko, M.P. Prokhorova, O.F. Chernii, V.YE. Khomenko, O.V. Iemets, N.V. Gryshchenko, O.L. Kovalchuk, A.V. Kupkina

    Background. The coronavirus disease 2019 ­(COVID-19) pandemic and the war have significantly affected the state of national medical systems and the health of the population, especially children. The purpose of the study is to analyze the impact of the war and pandemic consequences on the health status of children in the first year of life from 2020 to 2023 in Ukraine. ­Materials and methods. A retrospective analysis of the birth rate and the number of children in Ukraine, the frequency of breastfeeding, and the morbidity of children in the first year of life in Ukraine from 2020 to 2023 was conducted according to the data of the Public Health Centre of the Ministry of Health of Ukraine. Methods of systematic approach and epidemiological analysis were used. Results. In the last four years during the war and the ­COVID-19 pandemic, the number of children in Ukraine decreased to 5.5 million, or by 19.3 %, compared to 2020. The number of infants decreased even more, by 43.06 %, due to a 30.5 % decrease in the birth rate compared to 2020 (p < 0.01). The proportion of children who stopped breastfeeding at 3 months increased by 11.67 % between 2020 and 2023, while the number of those who stopped breastfeeding at 6 months decreased slightly, by 3.97 %. The largest increase in the proportion of children who stopped breastfeeding at these ages was observed in the Donetsk, Luhansk and Zapo­rizhzhia regions, where the most intense hostilities are taking place. An increase in the morbidity rate among children in the first year of life to 1463.5 ‰, or by 19.9 % compared to 2020, and its return to the levels observed in the middle of the last decade indicate the negative impact of direct and indirect war-related factors on the health status of children in the first year of life, and, probably, a limited access to health care in areas where hostilities continue and those been de-occupied. Respiratory diseases, especially acute upper respiratory diseases, pneumonia, influenza, certain perinatal conditions, diseases of the skin and subcutaneous tissues, digestive disorders, nervous system and blood diseases are the main causes of morbidity among children in the first year of life. Conclusions. The war and the consequences of the COVID-19 pandemic have had a negative impact on the birth rate, the number of the child population in Ukraine. Morbidity rates among infants have increased, and breastfeeding rates and vaccination coverage have decreased.


  • Open Access

    Effectiveness of allergen-specific immunotherapy in children with bronchial asthma sensitized to house dust mites

    by M.P. Prokhorova, O.P. Volosovets, S.P. Kryvopustov, A.V. Kupkina, T.M. Volosovets

    Background. The only method of treatment that can change the natural course of allergies is allergen-specific immunotherapy, which allows reducing the sensitivity of the child’s body to the causative allergen and decreasing the activity of chronic inflammation. The evidence base for the effectiveness of allergen-specific immunotherapy in the treatment of bronchial asthma (BA) has significantly expanded recently. However, the truly important results remain too limited to make clinically useful conclusions about the efficacy of sublingual allergen-specific immunotherapy (SLIT) in people with BA and further evidence is needed. The purpose of the study is to evaluate the effectiveness of SLIT as an additional treatment for atopic BA of varying severity in children sensitized to house dust mites. Materials and methods. The main group consisted of 80 children with BA aged from 5 to 17 years, they were divided into three groups according to the severity of the disease: group 1 — 20 children with mild intermittent asthma, group 2 — 30 children with mild persistent asthma, group 3 — 30 children with moderately severe persistent asthma. Thirty practically healthy children without BA were also examined as a control group. For SLIT, a sublingual ORALTEK spray produced by Inmunotek (Spain) was used, a mixture of house dust mite allergens Dermatophagoides pteronyssinus 50 %/Dermatophagoides farinae 50 %, 1 ml of the solution contains 30,000 IU of natural allergen extract. To assess the effectiveness of the treatment, we conducted an analysis of the total score of clinical manifestations of asthma and allergic rhinitis and the degree of asthma control according to the Asthma Control Test. We also analyzed the state of cellular and humoral immunity in the dynamics of therapy. These indicators were evaluated within 1 month before the beginning and a month after the end of the one-year course of therapy. To assess the validity and reliability of the obtained results, statistical data processing was carried out using Microsoft Excel 2016 and Statistica for Windows 10 programs. The Student’s t-test was applied to assess the reliability of the results. The difference between the compared values was considered statistically significant at p < 0.05. Results. The results of the statistical analysis confirmed a significant improvement in the control indicators of patients who received SLIT: reduction in the total score of clinical manifestations, the frequency of clinical symptoms and the use of emergency drugs (p < 0.05). By the end of the study, the dynamics of a decrease in these indicators compared to the data before the start of treatment (according to the above list) was as follows: in patients of group 1 — 82.5, 91.8, 94.5 %, in patients of group 2 — 80.5, 88.4, 92.7 %, in patients of group 3 — 76.7, 85.3, 91.2 %. After treatment with the addition of SLIT to the basic therapy, a reliable increase in IgE and sIgA was observed, an increase in the spontaneous proliferative response of T-lymphocytes to the mitogen in all three groups to the level of the controls, a probable decrease in eosinophilic inflammation and an improvement in indicators of the cellular and humoral immunity (p < 0.001). Conclusions. The prescription of SLIT to children with mild intermittent BA, mild persistent BA and perennial allergic rhinitis, moderate persistent BA and perennial allergic rhinitis provides an opportunity to obtain stable control of the disease, reduces the number of visits to the doctor and justifies the wide use of this method in clinical allergy practice.


  • Open Access

    Bronchial asthma in children of Ukraine: medical and environmental parallels of morbidity and prevalence

    by O. P. Volosovets, Y. K. Bolbot, S. P. Kryvopustov, O. V. Mozyrska, M. V. Kryvopustova, M. P. Prokhorova, A. V. Kupkina

    Bronchial asthma in children of Ukraine: medical and environmental parallels of morbidity and prevalence